Autopsy report · NCT03557684
Leucine for Depression Study (L-DEP)
Cause of deathStaffing, sites or logistics
“COVID-19”
Life of this trial
- Registered 3 months before it started.
- Ran for about 2 years 11 months before it stopped.
- 59 participants enrolled.
- Results were posted on the registry 1 year 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Early Phase 1
- Sponsor
- University of California, Los Angeles
- Sponsor type
- University, hospital or other
- Conditions
- Depression
- Interventions
- leucine; PO placebo; lipopolysaccharide (LPS); IV placebo
- Participants
- 59
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.